Teva
CINQAIR
Manufacturer:
Teva
Name:
CINQAIR
HCPCS Code Descriptor:
Injection, reslizumab, 1 mg
Category:
J Code
HCPCS:
J2786
NDC(s):
59310-0610-31
Primary Type:
Anti-Eosinophil Asthma
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
CINQAIR is an Anti-Eosinophil Asthma drug manufactured by Teva and administered via the Intravenous route of administration. The J Code: J2786 is aligned to the drug CINQAIR.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/17
HCPCS Effective Date:
1/1/17
HCPCS Short Description:
Injection, reslizumab, 1mg
Billing and Coding Guide:
https://www.tevasupportsolutions.com/globalassets/tss-hcp/pdfs/at-a-glance-guide-to-codes-cinqair.pdf
Patient Assistance:
https://www.tevasupportsolutions.com/patients/